Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
- Status
- COMPLETED
- Phase
- PHASE3
S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE3
Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Chemoradiation With Capecitabine and Cetuximab
- Status
- COMPLETED
- Phase
- PHASE2
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1